Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children

Cancer Causes and Control

Volumn 26, Issue 4, 2015, Pages 609-619

  Hsu, Ling I ^a   Chokkalingam, Anand P ^a   Briggs, Farren B S ^e   Walsh, Kyle ^b   Crouse, Vonda ^c   Fu, Cecilia ^d   Metayer, Catherine ^a   Wiemels, Joseph L ^b   Barcellos, Lisa F ^a   Buffler, Patricia A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Department of Orthopaedic Surgery Central California Children's Hospital   (United States)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Childhood leukemia; Early life infections; Genetic association; Gene environment interaction

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARID5B GENE; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CEBPE GENE; CHILD; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; ETHNICITY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HIGH RISK POPULATION; HISPANIC; HUMAN; IKZF1 GENE; IMMUNOPHENOTYPING; INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE; ONSET AGE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; CALIFORNIA; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; INFANT; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD; STATISTICAL MODEL;

ARID5B PROTEIN, HUMAN; CCAAT ENHANCER BINDING PROTEIN; CEBPE PROTEIN, HUMAN; DNA BINDING PROTEIN; IKAROS TRANSCRIPTION FACTOR; IKZF1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ALLELES; CALIFORNIA; CCAAT-ENHANCER-BINDING PROTEINS; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HISPANIC AMERICANS; HUMANS; IKAROS TRANSCRIPTION FACTOR; INFANT; LOGISTIC MODELS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRANSCRIPTION FACTORS;

EID: 84925467065     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-015-0550-3     Document Type: Article

References (52)

1. Kaatsch P (2010) Epidemiology of childhood cancer. Cancer Treat Rev 36(4):277–285
2. Pui CH, Relling MV, Downing JR (2004) Acute lymphoblastic leukemia. N Engl J Med 350(15):1535–1548
3. Eden T (2010) Aetiology of childhood leukaemia. Cancer Treat Rev 36(4):286–297
4. Urayama KY, Chokkalingam AP, Manabe A, Mizutani S (2013) Current evidence for an inherited genetic basis of childhood acute lymphoblastic leukemia. Int J Hematol 97(1):3–19
5. Vijayakrishnan J, Houlston RS (2010) Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Haematologica 95(8):1405–1414
6. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, Price A, Olver B, Sheridan E et al (2009) Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 41(9):1006–1010
7. Orsi L, Rudant J, Bonaventure A, Goujon-Bellec S, Corda E, Evans TJ et al (2012) Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE). Leukemia 26(12):2561–2564
8. Trevino LR, Yang W, French D, Hunger SP, Carroll WL, Devidas M et al (2009) Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 41(9):1001–1005
9. Xu H, Yang W, Perez-Andreu V, Devidas M, Fan Y, Cheng C, et al (2013) Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Cancer Inst
10. Greaves M (2006) Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 6(3):193–203
11. Ma X, Buffler PA, Wiemels JL, Selvin S, Metayer C, Loh M et al (2005) Ethnic difference in daycare attendance, early infections, and risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomark Prev 14(8):1928–1934
12. Hochberg Y, Benjamini Y (1990) More powerful procedures for multiple significance testing. Stat Med 9(7):811–818
13. Urayama KY, Buffler PA, Gallagher ER, Ayoob JM, Ma X (2010) A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia. Int J Epidemiol 39(3):718–732
14. Urayama KY, Ma X, Selvin S, Metayer C, Chokkalingam AP, Wiemels JL et al (2011) Early life exposure to infections and risk of childhood acute lymphoblastic leukemia. Int J Cancer 128(7):1632–1643
15. Westergaard T, Andersen PK, Pedersen JB, Olsen JH, Frisch M, Sorensen HT et al (1997) Birth characteristics, sibling patterns, and acute leukemia risk in childhood: a population-based cohort study. J Natl Cancer Inst 89(13):939–947
16. Dockerty JD, Draper G, Vincent T, Rowan SD, Bunch KJ (2001) Case-control study of parental age, parity and socioeconomic level in relation to childhood cancers. Int J Epidemiol 30(6):1428–1437
17. Roman E, Simpson J, Ansell P, Kinsey S, Mitchell CD, McKinney PA et al (2007) Childhood acute lymphoblastic leukemia and infections in the first year of life: a report from the United Kingdom Childhood Cancer Study. Am J Epidemiol 165(5):496–504
18. Rudant J, Orsi L, Menegaux F, Petit A, Baruchel A, Bertrand Y et al (2010) Childhood acute leukemia, early common infections, and allergy: the ESCALE study. Am J Epidemiol 172(9):1015–1027
19. O’Connor SM, Boneva RS (2007) Infectious etiologies of childhood leukemia: plausibility and challenges to proof. Environ Health Perspect 115(1):146–150
20. Campleman SLWW (1988) Childhood cancer in California, to 1999 Volume I: birth to age 14. Sacramento, CA: California department of health services. Cancer Surveill Sect 2004:16–17
21. Walsh KM, Chokkalingam AP, Hsu LI, Metayer C, de Smith AJ, Jacobs DI et al (2013) Associations between genome-wide Native American ancestry, known risk alleles and B-cell ALL risk in Hispanic children. Leukemia 27(12):2416–2419
22. Ma X, Buffler PA, Layefsky M, Does MB, Reynolds P (2004) Control selection strategies in case-control studies of childhood diseases. Am J Epidemiol 159(10):915–921
23. Bartley K, Metayer C, Selvin S, Ducore J, Buffler P (2010) Diagnostic X-rays and risk of childhood leukaemia. Int J Epidemiol 39(6):1628–1637
24. Aldrich MC, Zhang L, Wiemels JL, Ma X, Loh ML, Metayer C et al (2006) Cytogenetics of Hispanic and White children with acute lymphoblastic leukemia in California. Cancer Epidemiol Biomark Prev 15(3):578–581
25. Ma X, Buffler PA, Selvin S, Matthay KK, Wiencke JK, Wiemels JL et al (2002) Daycare attendance and risk of childhood acute lymphoblastic leukaemia. Br J Cancer 86(9):1419–1424
26. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559–575
27. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38(8):904–909
28. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O’Donnell CJ, de Bakker PI (2008) SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24(24):2938–2939
29. Yang TP, Beazley C, Montgomery SB, Dimas AS, Gutierrez-Arcelus M, Stranger BE et al (2010) Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies. Bioinformatics 26(19):2474–2476
30. Stranger BE, Nica AC, Forrest MS, Dimas A, Bird CP, Beazley C et al (2007) Population genomics of human gene expression. Nat Genet 39(10):1217–1224
31. Jewell N (2004) Statistics for epidemiology. Chapman & Hall/CRC, Boca Raton
32. Baye TM, Wilke RA (2010) Mapping genes that predict treatment outcome in admixed populations. Pharmacogenomics J 10(6):465–477
33. Han S, Lee KM, Park SK, Lee JE, Ahn HS, Shin HY et al (2010) Genome-wide association study of childhood acute lymphoblastic leukemia in Korea. Leuk Res 34(10):1271–1274
34. Prasad RB, Hosking FJ, Vijayakrishnan J, Papaemmanuil E, Koehler R, Greaves M et al (2010) Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood 115(9):1765–1767
35. Vijayakrishnan J, Sherborne AL, Sawangpanich R, Hongeng S, Houlston RS, Pakakasama S (2010) Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence. Leuk Lymphoma 51(10):1870–1874
36. Pastorczak A, Gorniak P, Sherborne A, Hosking F, Trelinska J, Lejman M et al (2011) Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population. Leuk Res 35(11):1534–1536
37. Healy J, Richer C, Bourgey M, Kritikou EA, Sinnett D (2010) Replication analysis confirms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia. Haematologica 95(9):1608–1611
38. Yang W, Trevino LR, Yang JJ, Scheet P, Pui CH, Evans WE et al (2010) ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence. Leukemia 24(4):894–896
39. Chokkalingam AP, Hsu LI, Metayer C, Hansen HM, Month SR, Barcellos LF et al (2013) Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics. Cancer Causes Control 24(10):1789–1795
40. John LB, Ward AC (2011) The Ikaros gene family: transcriptional regulators of hematopoiesis and immunity. Mol Immunol 48(9–10):1272–1278
41. Schmitt C, Tonnelle C, Dalloul A, Chabannon C, Debre P, Rebollo A (2002) Aiolos and Ikaros: regulators of lymphocyte development, homeostasis and lymphoproliferation. Apoptosis 7(3):277–284
42. Kuiper RP, Waanders E, van der Velden VH, van Reijmersdal SV, Venkatachalam R, Scheijen B et al (2010) IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. Leukemia 24(7):1258–1264
43. Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, Miller CB et al (2009) Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 360(5):470–480
44. Virely C, Moulin S, Cobaleda C, Lasgi C, Alberdi A, Soulier J et al (2010) Haploinsufficiency of the IKZF1 (IKAROS) tumor suppressor gene cooperates with BCR-ABL in a transgenic model of acute lymphoblastic leukemia. Leukemia 24(6):1200–1204
45. Greaves MF, Wiemels J (2003) Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 3(9):639–649
46. Walsh KM, de Smith AJ, Chokkalingam AP, Metayer C, Dahl GV, Hsu LI et al (2013) Novel childhood ALL susceptibility locus BMI1-PIP4K2A is specifically associated with the hyperdiploid subtype. Blood 121(23):4808–4809
47. Paulsson K, Forestier E, Lilljebjorn H, Heldrup J, Behrendtz M, Young BD et al (2010) Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. Proc Natl Acad Sci USA 107(50):21719–21724
48. Sherborne AL, Houlston RS (2010) What are genome-wide association studies telling us about B-cell tumor development? Oncotarget 1(5):367–372
49. Akagi T, Thoennissen NH, George A, Crooks G, Song JH, Okamoto R et al (2010) In vivo deficiency of both C/EBPbeta and C/EBPepsilon results in highly defective myeloid differentiation and lack of cytokine response. PLoS ONE 5(11):e15419
50. Bedi R, Du J, Sharma AK, Gomes I, Ackerman SJ (2009) Human C/EBP-epsilon activator and repressor isoforms differentially reprogram myeloid lineage commitment and differentiation. Blood 113(2):317–327
51. Akasaka T, Balasas T, Russell LJ, Sugimoto KJ, Majid A, Walewska R et al (2007) Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 109(8):3451–3461
52. Chokkalingam APAM, Bartley K, Hsu LI, Metayer C et al (2011) Matching on race and ethnicity in case–control studies as a means of control for population stratification. Epidemiology 1:101